Wolverine Asset Management LLC Pacira Bio Sciences, Inc. Put Options Transaction History

Wolverine Asset Management LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 04, 2024	SELL	$11.7 - $28.46 $1,170 - $2,846	-100 Reduced 0.39%	25,600 $385,000
Q2 2024 Aug 01, 2024	BUY	$25.5 - $31.51 $655,350 - $809,807	25,700 New	25,700 $735,000
Q2 2021 Aug 13, 2021	SELL	$59.18 - $69.99 $1.72 Million - $2.03 Million	-29,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $1.46 Million - $1.92 Million	29,000 New	29,000 $1.74 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $388,314 - $490,303	-9,400 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $164,250 - $260,000	-5,000 Reduced 34.72%	9,400 $462,000
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $467,500 - $676,600	-17,000 Reduced 54.14%	14,400 $461,000
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $689,540 - $1.07 Million	23,000 Added 273.81%	31,400 $978,000
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $267,540 - $394,380	8,400	8,400 $383,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.